Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

Yildirim, Mahmut EmreKaraca, MustafaArtac, MehmetCicin, IrfanGeredeli, CaglayanAlacacioglu, AhmetSimsek, Eda Tanrikulu2024-02-232024-02-2320220732-183X1527-7755https://hdl.handle.net/20.500.12452/17397Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2022 -- ELECTR NETWORK[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.Conference Object4016E15562E15562Q1WOS:000863680303045Q1